The Department of Infectious Diseases Research Team, in partnership with the Geelong Centre for Emerging Infectious Diseases (GCEID), is a multidisciplinary group that tackles the transmission, treatment and prevention of some of the public’s most pressing health challenges, including:
- Healthcare-associated infections
- Emerging infectious diseases
- Mycobacteria ulcerans (Buruli Ulcer)
- Infections of medical devices
- C. difficile infection
- Hepatitis C
- Infective endocarditis (infection of the heart)
- Antimicrobial resistance
In addition, we are leaders in the development of strategies and safeguards in the areas of refugee health and antimicrobial stewardship (responsible use of antibiotics).
Our Department is also a significant and active member of the Barwon Health Clinical Trials Unit (CTU), which, over 25 years and with the contribution of thousands of volunteers, is regarded as one of the leading hubs for clinical trials in the development of new treatments and technologies. The CTU is renowned for its start-up timelines and is a national lead on the majority of its global commercially sponsored clinical trials.
Last Modified: Friday, 18 March 2022